Alan A. Musso
Equibles does not estimate personal net worth.
Get an email with a short summary when Fulcrum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FULC alertsAbout Alan A. Musso
Alan A. Musso is recorded as CFO at Fulcrum Therapeutics, Inc. (FULC) since August 7, 2023. Fulcrum Therapeutics, Inc. reported in an 8-K filed August 3, 2023 that Alan A. Musso was appointed principal financial officer, effective August 7, 2023. Fulcrum Therapeutics, Inc. reported in an 8-K filed August 3, 2023 that Alan A. Musso was appointed chief financial officer and treasurer, effective August 7, 2023. Fulcrum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fulcrum Therapeutics, Inc. includes Alex C. Sapir (CEO and Board Member), Bryan Stuart (CEO, COO and Board Member), Robert J. Gould (CEO) and 7 others.
“Mr. Musso will also succeed Mr. Sapir, Fulcrum's president and chief executive officer, as principal financial officer, effective August 7, 2023.”
“On August 2, 2023, Fulcrum's board of directors, or the Board, appointed Alan A. Musso as Fulcrum's chief financial officer and treasurer, effective August 7, 2023.”
Affiliation history
-
Current
2023-08-07–present
-
Current
2023-08-07–present
Company network
Leadership on record at Fulcrum Therapeutics, Inc.
- Alex C. Sapir CEO, Board Member
- Bryan Stuart CEO, COO, Board Member
- Robert J. Gould CEO
- Kate Haviland Chairman
- Mark Levin Chairman
- Peter Thomson CFO
- Robert E. Gould CFO
- Mel Hayes COO
- Alan Musso Chief Accounting Officer
- Gregory Tourangeau Chief Accounting Officer